Amerikanische Gesellschaft für Hirudotherapie

Exploring the use of the medicinal leech: a clinical risk-benefit analysis

Risk-benefit analysis published in Journal of Reconstructive Microsurgery (1996)

Zuletzt aktualisiert: June 18, 2026Geprüft von: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Research reportKlinische StudienSicherheit & Infektionskontrollede Chalain TM · Journal of reconstructive microsurgery, 1996

Abstract

The medicinal leech, Hirudo medicinalis, has been used with increasing frequency for salvage of compromised pedicled flaps and microvascular free-tissue transfers. The data pertaining to 18 cases in which flap salvage with leeches was attempted were reviewed and contrasted with the data from 108 published cases from other centers. A further analysis isolated and examined 19 cases in which infection, secondary to leech utilization, supervened. Results suggested that successful salvage of tissue with leeches occurs in 70 to 80 percent of cases. In contrast, the infection rate of most series is between 7 and 20 percent and, when a clinically significant infection occurs, the flap salvage rate drops to 30 percent or less. In addition to infection, the risks of leech therapy include blood loss, which may require replacement transfusion, loss of leeches into body orifices and spaces, allergic reactions, and adverse psychological responses. Clinical indications and contraindications, and strategies to reduce the risks of leech usage, are discussed. Conclusions are that leeches are best used early, and in accordance with an accepted institutional protocol. For each case, the potential risks and benefits must be rigorously assessed and honestly applied.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal Article
Indexed MeSH termsAdultAeromonas hydrophilaAnimalsBlood TransfusionCase-Control StudiesFemaleGram-Negative Bacterial InfectionsHumansIncidenceLeechesMalePostoperative Complications

Zusammenfassung

Authoritative clinical risk-benefit analysis of medicinal leech therapy covering anticoagulant effect, blood loss, infection risk, allergic and ethical considerations.

Warum dies für die Hirudotherapie relevant ist

This article reviews 18 clinical cases and 108 published cases of medicinal leech (Hirudo medicinalis) use for salvaging compromised pedicled flaps and microvascular free-tissue transfers. It is highly relevant to the American Society of Hirudotherapy, providing concrete clinical data on the risk-benefit profile of leech therapy, noting a 70 to 80 percent tissue salvage success rate alongside a 7 to 20 percent infection rate that drastically reduces salvage success. While comprehensive, the analysis aggregates historical cases without a standardized, prospective control group. The abstract emphasizes that leech usage carries distinct risks—including blood loss requiring transfusion, allergic reactions, and psychological impacts—necessitating rigorous protocol-based assessment rather than casual application.

Zitation

Exploring the use of the medicinal leech: a clinical risk-benefit analysis.

de Chalain TM · Journal of reconstructive microsurgery, 1996

Verwandter klinischer Kontext

Zur ASH-Bibliothek hinzugefügt: May 27, 2026 · Letzte Aktualisierung der Website: June 18, 2026

Diese Website stellt Bildungsinformationen bereit und ist weder eine medizinische Beratung noch eine Diagnose oder Behandlungsempfehlung. Die medizinische Blutegeltherapie ist mit klinisch relevanten Risiken verbunden und sollte ausschließlich von qualifizierten Klinikerinnen und Klinikern unter institutionell genehmigten Protokollen durchgeführt werden. Die FDA-510(k)-Zulassung für medizinische Blutegel ist auf bestimmte Indikationen beschränkt; experimentelle und Off-Label-Diskussionen werden entsprechend gekennzeichnet. Für patientenspezifische Beratung wenden Sie sich an eine qualifizierte Gesundheitsfachkraft.